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Abstract: OBJECTIVES The purpose of this study was to examine sex-specific associations, if any, be-
tween per-vessel coronary artery disease (CAD) extent and the risk of major adverse cardiovascular events
(MACE) over a 5-year study duration. BACKGROUND The presence and extent of CAD diagnosed by
coronary computed tomography angiography (CTA) is associated with increased short-term mortality
and MACE. Nevertheless, some uncertainty remains regarding the influence of sex on these findings.
METHODS 5,632 patients (mean age 60.2 ± 11.8 years, 36.5% women) from the CONFIRM (Coronary
CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry were followed
for 5 years. Obstructive CAD was defined as ￿50% luminal stenosis in a coronary vessel. Using Cox
proportional hazards models, we calculated the hazard ratio (HR) for incident MACE among women
and men, defined as death or myocardial infarction. RESULTS Obstructive CAD was more prevalent in
men (42% vs. 26%; p < 0.001), whereas women were more likely to have normal coronary arteries (43%
vs. 27%; p < 0.001). There were a total of 798 incident MACE events. After adjustment, there was
a strong association between increased MACE risk and nonobstructive CAD (HR: 2.16 for women, 2.56
for men; p < 0.001 for both), obstructive 1-vessel CAD (HR: 3.69 and 2.66; p < 0.001), 2-vessel CAD
(HR: 3.92 and 3.55; p < 0.001), and 3-vessel/left main CAD (HR: 5.94 and 4.44; p < 0.001). Further
exploratory analyses of atherosclerotic burden did not identify sex-specific patterns predictive of MACE.
CONCLUSIONS In a large prospective coronary CTA cohort followed long-term, we did not observe an
interaction of sex for the association between MACE risk and increased per-vessel extent of obstructive
CAD. These findings highlight the persistent prognostic significance of anatomic CAD subsets as detected
by coronary CTA for the risk of MACE in both women and men.
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ABSTRACT
OBJECTIVES The purpose of this study was to examine sex-speciﬁc associations, if any, between per-vessel coronary
artery disease (CAD) extent and the risk of major adverse cardiovascular events (MACE) over a 5-year study duration.
BACKGROUND The presence and extent of CAD diagnosed by coronary computed tomography angiography (CTA) is
associated with increased short-term mortality and MACE. Nevertheless, some uncertainty remains regarding the inﬂu-
ence of sex on these ﬁndings.
METHODS 5,632 patients (mean age 60.2  11.8 years, 36.5% women) from the CONFIRM (Coronary CT Angiography
Evaluation for Clinical Outcomes: An International Multicenter) registry were followed for 5 years. Obstructive CAD was
deﬁned as $50% luminal stenosis in a coronary vessel. Using Cox proportional hazards models, we calculated the hazard
ratio (HR) for incident MACE among women and men, deﬁned as death or myocardial infarction.
RESULTS Obstructive CAD was more prevalent in men (42% vs. 26%; p < 0.001), whereas women were more likely to
have normal coronary arteries (43% vs. 27%; p < 0.001). There were a total of 798 incident MACE events. After
adjustment, there was a strong association between increased MACE risk and nonobstructive CAD (HR: 2.16 for
women, 2.56 for men; p < 0.001 for both), obstructive 1-vessel CAD (HR: 3.69 and 2.66; p < 0.001), 2-vessel CAD
(HR: 3.92 and 3.55; p < 0.001), and 3-vessel/left main CAD (HR: 5.94 and 4.44; p < 0.001). Further exploratory analyses
of atherosclerotic burden did not identify sex-speciﬁc patterns predictive of MACE.
CONCLUSIONS In a large prospective coronary CTA cohort followed long-term, we did not observe an interaction of
sex for the association between MACE risk and increased per-vessel extent of obstructive CAD. These ﬁndings highlight
the persistent prognostic signiﬁcance of anatomic CAD subsets as detected by coronary CTA for the risk of MACE in both
women and men. (J Am Coll Cardiol Img 2016;9:364–72) © 2016 by the American College of Cardiology Foundation.
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S ex disparities in coronary artery disease (CAD)outcomes are well documented (1–4). Althoughwomen tend to have a lower prevalence of
obstructive CAD, prior evidence indicates that
women are more likely to be admitted for angina pec-
toris and experience worsened outcomes after
myocardial infarction (MI) (5). Likewise, women
with symptomatic CAD are more likely to suffer worse
clinical outcomes, a ﬁnding present even among
women with apparently normal or nonobstructive
coronary arteries as evaluated by invasive coronary
angiography (6,7). In light of the considerable burden
of CAD in women, further improvements in risk strat-
iﬁcation are essential for guiding preventive strate-
gies and public health initiatives.
Coronary computed tomography angiography
(CTA) is a noninvasive imaging modality that enables
accurate detection and exclusion of CAD. Prior
epidemiological studies have demonstrated that the
presence and extent of anatomic CAD are associated
with a heightened risk of death as well as major
adverse cardiovascular events (MACE) within a 2-year
follow-up period (8–13). A chief limitation, however,
is the lack of certainty regarding the inﬂuence of sex
on these ﬁndings. One study reported that non-
obstructive CAD was associated with increased mor-
tality risk in women but not in men (8). A subsequent
propensity-matched study derived from similar data
documented an equivalent risk of mortality and MI
for nonobstructive CAD between sexes (13); however,
the latter study failed to examine the sex-speciﬁc
relationship between obstructive CAD and MACE.
Further still, most of the available published reports
have been unable to account for the risk beyond
3 years. Thus, an additional question is whether sex-
speciﬁc differences in risk persist or attenuate over a
longer duration of follow-up. Using data from a large
prospective coronary CTA registry, we therefore set
out to determine the sex-speciﬁc relationships, if any,
between the extent of CAD and risk of MACE over a
5-year study period.
METHODS
STUDY POPULATION. Study patients were
identiﬁed from the CONFIRM (Coronary CT
Angiography Evaluation for Clinical Out-
comes: An International Multicenter) registry,
a dynamic, international, multicenter, obser-
vational cohort study that prospectively col-
lects clinical, procedural, and follow-up data
on patients undergoing $64-detector row
coronary CTA. The rationale, design, site-
speciﬁc patient characteristics, and follow-up
durations have been described previously
(14). In brief, this study screened 12,086 pa-
tients with 5-year follow-up data who under-
went coronary CTA at 17 centers in 9 countries (Austria,
Canada, Germany, Israel, Italy, Portugal, South Korea,
Switzerland, and the United States) between 2002 and
2009. Individuals with known CAD at the time of cor-
onary CTA, as deﬁned by prior MI or coronary revas-
cularization or cardiac transplantation, were excluded
(n ¼ 1,593). Patients with incomplete follow-up of all
clinical events (n ¼ 4,585), with adverse events on the
day of the coronary CTA (n ¼ 50), with missing plaque
severity data (n ¼ 224), or those who were missing age
and sex information (n ¼ 2) were also omitted. Thus,
the analytic sample comprised 5,632 patients. Each
study site received institutional review board approval
for all registry procedures, including follow-up meth-
odologies, and each participant provided written
informed consent.
CLINICAL DATA COLLECTION. Standardized data
collection methods were used at the participating
study sites. Data were systematically collected for
each consecutive patient while applying consistent
deﬁnitions for suspected cardiac symptoms, risk
factors, and angiographic CAD extent and severity.
Patient information was gathered for traditional car-
diac risk factors, including hypertension, diabetes,
dyslipidemia, current smoking, and a family history
of premature CAD. Patients who were treated for
hypertension, diabetes, or dyslipidemia, or who
otherwise had a prior diagnosis for these conditions
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were categorized as having that risk factor. Family
history of premature CAD was deﬁned as a primary
relative with a diagnosis early in life (i.e., mother
<65 years of age or father <55 years of age). Chest
pain was deﬁned and categorized by the interviewing
physician as nonanginal, atypical angina, or typical
angina pectoris. The presence of excessive dyspnea
as a reason for referral was also noted. The baseline
use of cardiac medications (aspirin, beta blockers,
angiotensin-converting enzyme/angiotensin receptor
blocker, statin) were also collected.
CORONARY CTA PERFORMANCE AND INTERPRETATION.
Standardized protocols for image acquisition, as
deﬁned by the Society of Cardiovascular Computed
Tomography, were used at all participating sites (15).
Speciﬁc details of coronary CTA procedures have
been deﬁned in detail elsewhere (14). Each site
applied the standard anatomic segmental analysis for
image interpretation. Plaque composition was
deﬁned as noncalciﬁed, partially calciﬁed, or calci-
ﬁed. All segments were coded for the presence and
severity of coronary stenosis and were scored as
normal (0% luminal stenosis), mild-moderate (1% to
49% luminal stenosis), moderate (50% to 69% luminal
stenosis), or severe ($70% luminal stenosis). For the
primary analysis, CAD extent was deﬁned by $50%
stenosis in 0, 1, 2, or 3 coronary artery vessels. As
reported in prior studies (8,9,16), given its prognostic
signiﬁcance, left main disease (50% luminal stenosis)
was grouped with 3-vessel obstructive CAD.
Limited exploratory analyses of plaque composi-
tion and per-segment severity were also performed
using previously reported methods (8). A segment
involvement score was calculated as the total num-
ber of coronary artery segments exhibiting plaque,
irrespective of the degree of luminal stenosis within
each segment (minimum ¼ 0; maximum ¼ 16). A
segment stenosis score was used as a measure of
overall coronary artery plaque extent. Each individ-
ual coronary segment was graded as having no to
severe plaque (i.e., scores from 0 to 3) based on
extent of obstruction of coronary luminal diameter.
Then the extent scores of all 16 individual segments
were summed to yield a total score ranging from
0 to 48.
STUDY OUTCOME. Patients were followed prospec-
tively for 5 years. The primary outcome measure
for the present study was MACE, which included a
combination of all-cause mortality and nonfatal
MI. Secondary exploratory outcomes were all-cause
mortality and nonfatal MI. Cause of death was not
obtained in the CONFIRM registry. Late revas-
cularization was not included as an outcome owing
to insufﬁcient data. Follow-up procedures were
approved by all study centers’ institutional review
boards. All-cause mortality was adjudicated by trained
study personnel or by querying of national medical
databases. Other events were collected through a
combination of direct questioning of patients using a
scripted interview and examination of the patients’
medical records as previously described (14). Acute
MI was further ascertained using biomarker quantiﬁ-
cation during patients’ hospital stays.
STATISTICAL METHODS. Demographic characteris-
tics were summarized according to sex, with catego-
rical variables presented as counts with proportions
and continuous variables as mean  SD, unless
speciﬁed otherwise. Categorical variables were
compared with the chi-square test, whereas contin-
uous variables were compared with Student unpaired
t test or Wilcoxon nonparametric tests where appro-
priate. Kaplan-Meier curves with log-rank tests
were used to assess the sex-speciﬁc relationship
between CAD extent and MACE. Next, we attempted
to select the most relevant candidate risk factors for
TABLE 1 Study Demographics
Overall
(n ¼ 5,632)
Women
(n ¼ 2,056)
Men
(n ¼ 3,576) p Value
Age, yrs 60.2  11.8 62.4  11.4 58.9  11.8 <0.001
Cardiac risk factors
Hypertension 3,079 (54.9) 1,234 (60.3) 1,845 (51.9) <0.001
Hyperlipidemia 3,031 (54.1) 1,133 (55.3) 1,898 (53.3) 0.15
Diabetes 961 (17.1) 358 (17.5) 603 (16.9) 0.61
Current smoker 1,193 (21.4) 306 (15.0) 887 (25.0) <0.001
Family history of
premature CAD
1,662 (29.9) 674 (33.2) 988 (28.0) <0.001
Chest pain <0.001
Typical 739 (14.8) 292 (15.8) 447 (14.1)
Atypical 1,625 (32.4) 651 (35.3) 974 (30.8)
Noncardiac 664 (13.3) 298 (16.2) 366 (11.6)
Asymptomatic 1,983 (39.6) 603 (32.7) 1,380 (43.6)
Dyspnea 734 (16.8) 328 (20.2) 406 (14.7) <0.001
Baseline medication use
ASA 1,443 (32.6) 491 (30.5) 952 (33.8) 0.02
Beta blocker 1,289 (29.1) 498 (30.9) 791 (28.1) 0.05
ACEI/ARB 1,273 (28.8) 439 (27.3) 834 (29.6) 0.1
Statin 1,603 (36.0) 588 (36.3) 1,015 (35.9) 0.78
Extent of CAD by coronary CTA
Normal 1,844 (32.7) 878 (42.7) 966 (27.0) <0.001
Nonobstructive CAD 1,690 (30.0) 611 (29.7) 1,079 (30.2) 0.72
1-vessel obstructive CAD 1,094 (19.4) 318 (15.5) 776 (21.7) <0.001
2-vessel obstructive CAD 544 (9.7) 135 (6.6) 409 (11.4) <0.001
3-vessel/LM obstructive CAD 460 (8.2) 114 (5.5) 346 (9.7) <0.001
Early revascularization
(<90 days)
1,243 (22.1) 345 (16.8) 898 (25.1) <0.001
Values are mean  SD or n (%).
ACEI ¼ angiotensin-converting enzyme inhibitor; ARB ¼ angiotensin receptor blocker; ASA ¼ acetylsalicylic
acid; CAD ¼ coronary artery disease; CTA ¼ computed tomography angiography; LM ¼ left main.
Schulman-Marcus et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 9 , N O . 4 , 2 0 1 6
Sex, Plaque, and MACE in CONFIRM Registry A P R I L 2 0 1 6 : 3 6 4 – 7 2
366
multivariate adjustment using a stepwise Cox
regression procedure, reporting hazard ratios (HRs)
with 95% conﬁdence intervals (CIs). Initially, we
modeled associations between each clinical risk fac-
tor and MACE, selecting a subset of covariates with a
p value <0.25 in univariate analyses. We then used
a backward multivariate regression model with a
covariant retention threshold set at a p value
of <0.10. We chose a less-conservative p value of 0.10
to permit inclusion of covariates that are traditionally
associated with cardiovascular risk but were not
deemed signiﬁcant at the conventional threshold
p value of <0.05. Categorical variables were retained
if 1 component was signiﬁcant. As a sensitivity check,
and to conform to prior studies reported from the
CONFIRM registry (9), patients who underwent early
revascularization procedures #90 days previous were
excluded from all survival analyses (n ¼ 1,245). Vari-
ables retained in the ﬁnal Cox model were also used
as covariates during exploratory analyses of various
plaque characteristics. For the purpose of this study,
we also tested for an interaction between sex
and each of the coronary CTA characteristics with
the study outcomes. A 2-tailed p value <0.05 was
considered statistically signiﬁcant. All statistical
analyses were conducted using STATA version 12
(StataCorp, College Station, Texas).
RESULTS
BASELINE CHARACTERISTICS. Of 5,632 patients
included in the study, 2,056 (36.5%) were women.
The mean age of the cohort was 60.2  11.8 years;
women were signiﬁcantly older than men (mean 62.4
vs. 58.9, p < 0.001). Demographic data are displayed
in Table 1. Men were more likely to be smokers,
whereas women were more likely to have hyperten-
sion, a family history of premature CAD, symptoms of
chest pain, and excessive dyspnea (p < 0.001 for all).
With regard to the extent of visualized atheroscle-
rosis, men had an increased number of vessels with
obstructive CAD, whereas women were more likely to
have normal coronary arteries (p < 0.001 for all).
There were a total of 371 deaths and 484 MIs in the
cohort; 798 ﬁrst MACE events were used for analyses.
No sex-speciﬁc differences in the number of deaths or
MIs were observed.
CLINICAL CHARACTERISTICS ASSOCIATED WITH MACE.
The results of the multivariate model construction
procedures are reported in Table 2. All variables were
entered into the backward regression except for
female sex (p ¼ 0.68) and family history (p ¼ 0.32).
Of candidate risk factors, age, hypertension, dia-
betes, tobacco use, angiotensin-converting enzyme/
angiotensin receptor blocker use, angina typicality,
and per-vessel CAD severity were retained as impor-
tant predictors of MACE. Sex was not a signiﬁcant
predictor of MACE when forced into the ﬁnal multi-
variate model (HR: 0.86; 95% CI: 0.71 to 1.04; p ¼
0.12). All variables remained signiﬁcantly associated
with MACE in the multivariate Cox proportional
hazards model with the exception of some angina
variants.
CAD EXTENT AND MACE. In multivariate regression
analyses, an increasing number of vessels with
obstructive CAD was associated with increased MACE
risk in a dose-response relationship (Figure 1). As
displayed in Figure 2, increased per-vessel CAD extent
was associated with MACE risk over time in both
women and men (p < 0.001 by log-rank test for both).
After adjustment, increasing per-vessel CAD extent
was signiﬁcantly associated with increased MACE risk
in a manner similar to the overall cohort in both
women and men (Table 3) (p for interaction ¼ 0.98).
In exploratory analyses of secondary outcomes,
there was no clear stepwise relationship between the
number of diseased vessels and all-cause mortality
in either sex (p for interaction ¼ 0.58). Notably, in
both women and men, the adjusted point esti-
mates trended toward increased hazard of death
TABLE 2 Predictors of MACE
Univariate Multivariate*
HR (95% CI) p Value HR (95% CI) p Value
Age 1.04 (1.03–1.05) <0.001 1.03 (1.02–1.04) <0.001
Women 0.97 (0.84–1.12) 0.68
Hypertension 1.51 (1.31–1.75) <0.001 1.24 (1.02–1.51) 0.035
Hyperlipidemia 0.93 (0.81–1.07) 0.32
Diabetes 1.92 (1.64–2.25) <0.001 1.42 (1.16–1.74) 0.001
Smoking 1.20 (1.03–1.41) 0.03 1.48 (1.21–1.82) <0.001
Family history of
premature CAD
0.90 (0.77–1.06) 0.21
Typical angina 1.52 (1.25–1.85) <0.001 1.30 (1.01–1.66) 0.038
Atypical angina 0.98 (0.83–1.16) 0.82 0.99 (0.79–1.24) 0.904
Noncardiac chest pain 0.84 (0.67–1.05) 0.12 1.12 (0.85–1.66) 0.396
Dyspnea 1.50 (1.22–1.84) <0.001
Aspirin 1.63 (1.37–1.94) <0.001
Beta blocker 1.25 (1.04–1.50) 0.02
ACE/ARB 1.58 (1.32–1.88) <0.001 1.26 (1.04–1.52) 0.017
Statin 1.36 (1.14–1.62) <0.001
Nonobstructive disease 0.95 (0.81–1.10) 0.47 2.25 (1.66–3.05) <0.001
1-vessel obstructive disease 1.65 (1.40–1.93) <0.001 2.86 (2.08–3.94) <0.001
2-vessel obstructive disease 1.73 (1.41–2.11) <0.001 3.46 (2.44–4.91) <0.001
3-vessel obstructive disease 2.42 (1.99–2.95) <0.001 4.68 (3.31–6.61) <0.001
Early revascularization 2.41 (2.07–2.80) <0.001
*HRs shown only for variables retained.
ACE ¼ angiotensin-converting enzyme; CI ¼ conﬁdence interval; HR ¼ hazard ratio; MACE ¼ major adverse
cardiovascular events; other abbreviations as in Table 1.
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for both nonobstructive and obstructive disease.
Conversely, in both women and men, there appeared
to be a stepwise relationship between the secondary
outcome of nonfatal MI and number of diseased
vessels after adjustment for covariates (p for inter-
action ¼ 0.93). These ﬁndings were not materially
different when patients with early revascularization
(#90 days after the index coronary CTA) were
removed as a sensitivity check (data not shown).
SEX-SPECIFIC PLAQUE PATTERNS AND MACE. In
exploratory analyses of other per-patient and per-
segment measures, men had a higher prevalence
of atherosclerotic plaque and obstructive CAD
(Table 4). After adjustment, all measures of in-
creased atherosclerotic severity and extent were
associated with increased MACE risk in women and
men. There were no signiﬁcant sex-speciﬁc in-
teractions, with the exception that increased seg-
ments of calciﬁed plaque were associated with
increased MACE risk in women but not in men
(p for interaction ¼ 0.004).
DISCUSSION
In the present study, we observed a strong and
independent association between increased extent of
per-vessel obstructive CAD by coronary CTA and
heightened risk of MACE over a 5-year period among
women and men. Similar ﬁndings were observed for
the secondary outcome of nonfatal MI in both sexes,
whereas increased mortality risk was more uniform
across the spectrum of anatomic CAD. These ﬁndings
highlight the persistent prognostic signiﬁcance of
increased CAD extent as detected by coronary CTA for
both women and men.
The current study observations are ﬁtting with
previous observations; that is, although obstructive
CAD detected by coronary CTA is less common in
women than in men, its presence is associated with
equal if not worse adverse outcomes. In an analysis of
24,775 patients followed over a mean of 2.3 years,
Min et al. (8) found that although increased mortality
risk was noted in both men and women with
FIGURE 1 Multivariate Cox Regression Model for Risk of MACE
Normal
Nonobstructive
1-vessel obstructive
2-vessel obstructive
3-vessel obstructive/LM
Normal Nonobstructive 1-vessel obstructive 2-vessel obstructive 3-vessel obstructive/LM
12.00
10.00
8.00
6.00
4.00
2.00
0.00
MACE Death MI
MACE
Adjusted HR (95% CI) P-value
 Ref Ref
 2.25 (1.66 - 3.05) <0.001
 2.86 (2.08 - 3.94) <0.001
 3.46 (2.44 - 4.91) <0.001
 4.68 (3.31 - 6.61) <0.001
Death
Adjusted HR (95% CI) P-value
 Ref Ref
 1.71 (1.19 - 2.46) 0.004
 1.48 (0.97 - 2.23) 0.064
 1.46 (0.91 - 2.36) 0.117
 1.70 (1.05 - 2.75) 0.030
MI
Adjusted HR (95% CI) P-value
 Ref Ref
 3.03 (1.85 - 4.96) <0.001
 5.57 (3.41 - 9.10) <0.001
 7.55 (4.50 - 12.67) <0.001
 11.71 (7.04 - 19.48) <0.001
H
az
ar
d 
Ra
tio
Increasing number of vessels with obstructive coronary artery disease associated with a monotonic rise in major adverse cardiovascular events
(MACE) risk. CI ¼ conﬁdence interval; HR ¼ hazard ratio; LM ¼ left main; MI ¼ myocardial infarction; Ref ¼ reference.
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nonobstructive, 1-vessel, and 2-vessel obstructive
disease, in women 3-vessel/left main obstructive
disease was associated with an even higher mortality
risk compared with men (HR: 4.21 compared with
3.27). In a smaller single-center cohort of 1,127 pa-
tients (57% women), Shaw et al. (16) also observed
that although higher obstructive CAD burden by cor-
onary CTA was associated with increased mortality in
both sexes, women with 3-vessel obstructive/left
main disease had a higher risk of death compared
with men. These ﬁndings are in concord with prior
registry data demonstrating higher rates of in-
hospital mortality in women with obstructive CAD
(17). Our study extends the prior published reports by
observing the attenuation of the aforementioned sex-
speciﬁc differences in MACE over a longer duration.
However, our study emphasizes the core ﬁnding of
the prior published reports that the extent of
obstructive CAD detected by coronary CTA, regardless
of sex, is the most signiﬁcant predictor of increased
MACE risk.
The present study ﬁndings are also in line with
those of Leipsic et al. (13), who observed an associ-
ation between increased risk of MACE and non-
obstructive CAD by coronary CTA and no signiﬁcant
disparity between women and men. In that study,
over the course of 2.3 years, the authors made use of
propensity analysis to match patients with normal
coronary arteries and nonobstructive CAD by coro-
nary CTA for age and CAD risk factors. Following
this approach, the annual death, MI, or MACE rates
for both women and men with nonobstructive CAD
were equivalent. This analysis stands in contrast to
other coronary CTA and retrospective invasive
studies suggesting a unique adverse prognosis for
nonobstructive CAD by coronary CTA in women
compared with men (1,6,7,18). Our study re-enforces
the ﬁndings of Leipsic et al. (13) by observing a
similar attenuation in sex-speciﬁc MACE risk for
nonobstructive CAD over a longer time frame and
with a larger number of events available for anal-
ysis. Further still, the present study highlights that
nonobstructive CAD is associated with increased
risk of MACE in men as well as women (19), and
its presence in the former category should not be
overlooked.
Although this study did not identify sex differ-
ences in MACE risk for several measures of CAD
severity and extent, it must be emphasized that
our ﬁndings do not exclude sex differences in
the pathophysiology and functional importance of
atherosclerosis. For example, an intriguing study of
early atherosclerosis using intravascular ultrasound
reported that women have lower measures of
TABLE 3 Adjusted Hazards of MACE and MACE Components by CAD Extent,
Stratiﬁed by Sex
Women Men
Adjusted HR (95% CI) p Value Adjusted HR (95% CI) p Value
Total MACE
Normal Ref Ref Ref Ref
Nonobstructive 2.16 (1.41–3.29) <0.001 2.56 (1.62–4.04) <0.001
1-vessel obstructive 3.69 (2.35–5.78) <0.001 2.66 (1.66–4.26) <0.001
2-vessel obstructive 3.92 (2.24–6.85) <0.001 3.55 (2.17–5.79) <0.001
3-vessel obstructive/LM 5.94 (3.47–10.17) <0.001 4.44 (2.73–7.22) <0.001
Death
Normal Ref Ref Ref Ref
Nonobstructive 1.89 (1.14–3.16) 0.013 1.74 (1.02–2.97) 0.042
1-vessel obstructive 1.96 (1.07–3.58) 0.028 1.33 (0.75–2.38) 0.314
2-vessel obstructive 2.06 (0.95–4.45) 0.066 1.35 (0.71–2.56) 0.346
3-vessel obstructive/LM 1.66 (0.70–3.98) 0.253 1.76 (0.94–3.29) 0.064
MI
Normal Ref Ref Ref Ref
Nonobstructive 2.38 (1.22–4.61) 0.011 4.58 (2.02–10.35) <0.001
1-vessel obstructive 5.96 (3.11–11.40) <0.001 6.79 (3.01–15.32) <0.001
2-vessel obstructive 6.26 (2.86–13.69) <0.001 10.42 (4.57–23.80) <0.001
3-vessel obstructive/LM 14.04 (6.89–28.61) <0.001 13.57 (5.96–30.89) <0.001
MI ¼ myocardial infarction; Ref ¼ reference; other abbreviations as in Tables 1 and 2.
FIGURE 2 Kaplan-Meier Event-Free Survival Curves
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Increased per-vessel coronary artery disease extent was associated with greater major
adverse cardiovascular event risk over time in (A) women and (B) men (p < 0.001 by log-
rank test for both). VD ¼ vessel disease; other abbreviation as in Figure 1.
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microvascular dysfunction, whereas men tend to
have a higher burden of atheroma and endothelial
dysfunction in epicardial arteries (20). In addition,
prior research has shown that women with non-
obstructive CAD but who present with chest pain and
apparently normal invasive angiograms have
increased rates of microvascular dysfunction, which
is associated with a higher burden of clinical out-
comes (18). Differing mechanisms of plaque disrup-
tion in acute MI have been noted between men and
women (3). Finally, although rigorous and clinically
relevant, the measures of CAD extent used in the
present study are relatively crude. Given these con-
siderations, further studies are needed to distinguish
whether there are sex-speciﬁc plaque characteristics
detected by coronary CTA, and whether these are
associated with a higher risk of clinical events.
STUDY LIMITATIONS. Although CONFIRM represents
the largest consecutive cohort of patients undergoing
coronary CTA, as a registry it is subject to potential
selection and referral bias. Many of the patients with
long-term follow-up had incomplete outcomes data
regarding MI and were excluded from this study.
Thus, in spite of a lengthy follow-up and a relatively
high number of events, the analyses relative to
several sex-speciﬁc subgroups may have been un-
derpowered, which likely explains the wide 95% CIs
TABLE 4 Plaque Patterns and Adjusted Risk of MACE, Stratiﬁed by Sex
Demographics Adjusted HR* (95% CI)
Women Men p Value Women p Value Men p Value
Per patient
CACS <0.001
None 766 (55.3) 760 (37.1) 1.00 1.00 1.00 1.00
1–400 470 (33.9) 901 (44.0) 1.76 (1.11–2.78) 0.02 1.93 (1.18–3.16) 0.01
$400 149 (10.8) 388 (18.9) 2.86 (1.65–4.95) <0.001 2.41 (1.41–4.13) 0.001
Maximal CAD stenosis severity <0.001
No plaque 878 (42.7) 966 (27.0) 1.00 1.00 1.00 1.00
Mild (1%–49%) 611 (29.7) 1,079 (30.2) 2.14 (1.40–3.26) <0.001 2.56 (1.62–4.03) <0.001
Moderate (50%–69%) 215 (10.5) 538 (15.0) 3.64 (2.25–5.88) <0.001 2.62 (1.61–4.28) <0.001
Severe ($70%) 352 (17.1) 993 (27.8) 4.50 (2.89–7.01) <0.001 3.74 (2.38–5.87) <0.001
Location of any obstructive CAD
RCA 258 (13.0) 726 (21.1) <0.001 1.99 (1.39–2.84) <0.001 1.62 (1.27–2.07) <0.001
LAD artery 436 (21.5) 1,176 (33.2) <0.001 2.54 (1.86–3.47) <0.001 1.45 (1.15–1.83) 0.002
LCX artery 184 (9.5) 631 (18.6) <0.001 2.58 (1.78–3.74) <0.001 1.83 (1.43–2.33) <0.001
LM 32 (1.6) 95 (2.8) 0.006 1.99 (0.92–4.30) 0.08 1.21 (0.70–2.09) 0.49
Per segment
CAD severity and extent
Log segment involvement score 0.8 (0.0–1.4) 1.1 (0.0–1.8) <0.001 2.04 (1.68–2.49) <0.001 1.59 (1.36–1.87) <0.001
Log segment stenosis score 0.9 (0.0–1.6) 1.3 (0.0–2.1) <0.001 1.88 (1.60–2.21) <0.001 1.53 (1.34–1.74) <0.001
No. of segments with NCP <0.001
0 1,668 (82.8) 2,535 (74.5) 1.00 1.00 1.00 1.00
1 205 (10.2) 415 (12.2) 1.14 (0.75–1.74) 0.53 1.09 (0.79–1.52) 0.59
2 72 (3.6) 195 (5.7) 1.21 (0.62–2.39) 0.58 1.34 (0.89–2.01) 0.17
$3 69 (3.4) 257 (7.6) 1.12 (0.54–2.30) 0.77 1.02 (0.69–1.49) 0.93
No. of segments with PCP <0.001
0 1,632 (81.0) 2,289 (67.3) 1.00 1.00 1.00 1.00
1 189 (9.4) 401 (11.8) 1.24 (0.81–1.90) 0.32 1.02 (0.73–1.42) 0.93
2 76 (3.8) 259 (7.6) 1.45 (0.81–2.60) 0.21 1.13 (0.78–1.65) 0.51
$3 117 (5.8) 453 (13.3) 2.09 (1.35–3.25) 0.001 1.12 (0.83–1.50) 0.46
No. of segments with CP† <0.001
0 1,526 (75.8) 2,148 (63.1) 1.00 1.00 1.00 1.00
1 199 (9.9) 436 (12.8) 1.52 (0.99–2.36) 0.06 0.94 (0.67–1.34) 0.74
2 94 (4.7) 265 (7.8) 1.76 (1.02–3.05) 0.04 0.93 (0.62–1.39) 0.72
$3 195 (9.7) 553 (16.2) 2.39 (1.66–3.45) <0.001 1.11 (0.84–1.47) 0.47
Values are n (%) or median (interquartile range), unless otherwise indicated. *Adjusted for age, hypertension, diabetes, smoking, symptoms, and use of ACEI/ARB. †p for
interaction ¼ 0.004.
CACS ¼ coronary artery calcium score; CP ¼ calciﬁed plaque; IQR ¼ interquartile range; LAD ¼ left anterior descending; LCX ¼ left circumﬂex; NCP ¼ noncalciﬁed plaque;
PCP ¼ partially calciﬁed plaque; RCA ¼ right coronary artery; other abbreviations as in Tables 1 to 3.
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observed for some of the risk estimates reported in
this study. A further and important limitation is that
data were not collected on post–coronary CTA modi-
ﬁcations of pharmacotherapy or behavior. Studies in
other cohorts have demonstrated variable changes in
post-test medical therapy by degree of anatomic CAD
(21,22). It is unknown whether such treatment choices
are affected by sex, and this is a matter worthy of
further study. Data were also unavailable regarding
any stress testing, and so the functional signiﬁcance
of stenoses was unknown. Other clinically relevant
outcomes (e.g., cause-speciﬁc mortality, stroke) were
not collected. In light of these limitations, however,
this study is the largest consecutive cohort of patients
undergoing coronary CTA with long-term outcomes
data available.
CONCLUSIONS
The present study emphasized the clear prognostic
signiﬁcance of per-vessel obstructive CAD extent as
detected by coronary CTA over a 5-year period.
During this time, there were no distinct sex-speciﬁc
differences in the risk of MACE. Though our ﬁndings
await conﬁrmation through forthcoming studies, as
an initial step preventive strategies should be
encouraged for men and women who present with
any atherosclerosis as detected by coronary CTA.
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